Literature DB >> 10760819

Loss of type VI collagen in experimental and most spontaneous human fibrosarcomas.

B Trueb1, B F Odermatt.   

Abstract

Expression of type VI collagen, an adhesive protein of mesenchymal tissues, is significantly down-regulated upon viral transformation of fibroblasts. Likewise, most cell lines derived from spontaneous mesenchymal tumors, including fibrosarcomas, rhabdomyosarcomas, leiomyosarcomas, chondrosarcomas and liposarcomas, do not synthesize type VI collagen because they are not capable of expressing all 3 of the polypeptide chains required for the assembly of a functional heterotrimeric molecule. When injected into nude mice, neither fibrosarcoma cells (HT1080) nor rhabdomyosarcoma cells (A204) initiate the synthesis of type VI collagen, suggesting that the inhibition is not caused by deficiency of a paracrine factor. Immuno-histochemical studies further illustrate that 15 of 17 spontaneous adult fibrosarcomas lack type VI collagen in the tumor stroma. The absence of this important adhesion protein may contribute to tumorigenicity, invasiveness and/or metastasis of mesenchymal tumor cells. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760819     DOI: 10.1002/(sici)1097-0215(20000501)86:3<331::aid-ijc5>3.0.co;2-o

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.

Authors:  Hector Guillen-Ahlers; Steven A Buechler; Mark A Suckow; Francis J Castellino; Victoria A Ploplis
Journal:  Carcinogenesis       Date:  2008-05-21       Impact factor: 4.944

2.  Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression.

Authors:  Mieko Nishiu; Rempei Yanagawa; Shin-ichi Nakatsuka; Masayuki Yao; Tatsuhiko Tsunoda; Yusuke Nakamura; Katsuyuki Aozasa
Journal:  Jpn J Cancer Res       Date:  2002-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.